small molecule

VELPHORO

FERRIC OXYHYDROXIDE

Loss of exclusivityMay 2035latest FDA-listed patent expiry

CompanyVIFOR FRESENIUS MEDICAL CARE RENAL PHARMA FRANCE

Drug detail

Brand name	VELPHORO
Active ingredient	FERRIC OXYHYDROXIDE
Strength	EQ 500MG IRON
Dosage form	TABLET, CHEWABLE
Route	ORAL
Modality	Small molecule
FDA approval	November 2013
Marketing status	RX

Listed patents

Patent	Expires	Type
11234938*PED	May 2035	—
11446252*PED	May 2035	—
10624855*PED	May 2035	—
10624855	November 2034	product
11446252	November 2034	product
11234938	November 2034	product
9561251*PED	July 2030	—
9561251	January 2030	product
10695367*PED	May 2029	—
11013762*PED	May 2029	—
10925896*PED	May 2029	—
10925897*PED	May 2029	—
10933090*PED	May 2029	—
10682376*PED	May 2029	—
11013761*PED	May 2029	—
10925896	November 2028	product
10682376	November 2028	product
11013761	November 2028	product
10925897	November 2028	product
11013762	November 2028	product
10933090	November 2028	product
10695367	November 2028	product

Regulatory exclusivity

Code	Expires
PED	January 2028
NPP	July 2027

Source: FDA Orange Book, layered on the CliffBio company graph. Cliff dates are the latest FDA-listed patent expiry; estimates are projections, not legal advice.